we process in centrifuges at a certain temperature and speed , the whole blood is separated into the liquid part of the plasma and cellular erythrocytes, depending on applications, depending on our tasks. on this day, we receive plasma erythrocytes and platelets from a blood dose. three components from a blood dose. we are able to get from 1 heart donor the production of blood components - this is a refrigerated centrifuge, which allows you to separate blood into components into a liquid part into uniform elements. we work with belarusian centrifuges new models here that develop speeds up to 5.000 g, which allows you to get a quality component? blood components are waiting for the results

of the analysis, and the plasma goes into real quarantine for 6 months, it is immediately placed in the freezer. this keeps those important structures that we need in the future there, and all the prepared plasma undergoes mandatory quarantine storage for six months at a temperature of -30 ° and below. here we have the largest plasma storage. everything in the republic. we have about 16 tons of plasma annually about 110 tons of plasma are harvested in the republic, and about 65 tons of them are processed. and safe blood components , we must have a high-quality, not only safe, donor. products must be safe, for this we have a special

laboratory that checks the blood component for certain standards and these approval standards. our bank stores blood components, erythrocytes containing platelets, plasma and cryopredericipitate, frozen or milled - these are the main blood components at a temperature of -196 six degrees of storage in liquid nitrogen vapors, erythrocytes are stored for her canned, we use them both for transfusion with the phenotype of rare groups, and for immunization of donors.

we screen donated blood for 4 infections viral hepatitis hiv syphilis a very important analysis, we carry it out in order to secure the admission of blood-contaminated don

blood to a medical institution when an infection is detected, the blood is discarded from our medical institution. they come out. cars transport blood components prepared according to requests. in addition, during the day with their own transport from clinics they come and take away from us components that were not declared from us. all blood components are transported in a certain transport or certain conditions, i.e. storage temperature. a drug that is made from blood from living human blood for the purpose of extracting it must be borne in mind that with its very expensive, that is , exclusive and there is no blood substitute in the world

, nothing has been invented in the 21st century , there are no blood substitutes on the nose. in demand there will always be a service of blood. we are located in the city center of transphysiology, this is a structural subdivision of the minsk scientific and practical center, surgery, hematology transplantation is a unique institution where almost all medical care is concentrated. all, uh, profiles, these are hematological profile of patients with

hematological diseases, whose bone marrow does not function is narrowed, pheasant - hematopoiesis, which requires blood components. it's a surgical pathology, it's uh, the center. neurology hemodialis, so blood components are very relevant in our center. when the blood arrives at our department, before going to the patient, we carry out a series of manipulations, this determines the donor's blood type and redefines the patient's blood group, then we conduct a group compatibility test and a biological test directly in the patient's bed, only then it is transfused. this is a very honorable and responsible mission. every person. at least once sometime i should become a donor, this is an indescribable feeling when

you donate blood and you receive an sms notification. today your blood saved. human life. this is probably the most expensive and responsible feeling for a person. it helps others. here in our center it is always visible. our center is called scientific-practical. our first priority is science, so our practical production of blood components should serve physiological science. how many

future scientific technologies for medicine one of these areas is cell therapy, and we have been actively working for the past 15 years. and in principle, we have successes in the treatment of uh degenerative diseases, and the second direction. uh, this is, uh, the so-called or plasma enriched distribution of platelet factors. there are many scientific developments in the center, several laboratories that are engaged in cellular technologies with stem cells, laboratories, there are clinical transfusiology industrial air transfusiology

a b and c where two medical cell products are produced, stromal cells of the bone marrow are grown and everything will be sick when certain diseases. we work with neurologists with psychiatrists with traumatologists for diseases in which it is introduced spondylo destro dentistry. this is parkinson's epilepsy research is underway for premature babies in the process of this topic is coming. there are good results, if we put all this on the conveyor, and we get a registration certificate. it will be just profit medicine. it is very serious. we

work to very strict quality standards. in the center in brest, they are all the same. before you travel.